Health Catalyst provides data and analytics technology and professional services to healthcare organizations. Its core platform, Health Catalyst Ignite, extracts and unifies clinical, financial and operational data from source systems into a healthcare-specific data model, supporting self-service analytics and embedded AI; it is the successor to the company's earlier Data Operating System (DOS), whose clients are being migrated onto it. Around the platform sit analytics applications and tech-enabled managed services covering areas such as chart abstraction, interoperability and cybersecurity. Health Catalyst has traded on Nasdaq as HCAT since its July 2019 IPO and is headquartered in South Jordan, Utah.
Health Catalyst is publicly traded
IPO'd on Jul 25, 2019
This company is no longer available on our private secondary market. Shares can be traded publicly under HCAT.
Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Founded
2008
Employees
1,001–5,000
Total Funding
$377M
8 rounds
Last Private Valuation
$1B
Feb 2019
Simeon Kohl named Chief Executive Officer and President effective Sep 14, 2026; predecessor Ben Albert becomes Chief Business Officer and leaves the board
Second CEO change in seven months, alongside the Project Nexus restructuring
Launched 'Project Nexus' restructuring: ~9% global workforce cut plus ~100 open positions eliminated
Cost-cutting overhaul signals operating pressure; watch for margin/valuation impact
Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Total raised $377M across 8 rounds
Last updated 09-21-2026
| Date | Round | Amount Raised | Valuation | Lead Investors |
|---|---|---|---|---|
| Feb 2019 | Series F Press release | $100M | $1B | OrbiMed |
| Oct 30, 2017 | Series E extension | $55M | — | Norwest Venture Partners |
| Feb 29, 2016 | Series E | $70M | — | UPMC, Norwest Venture Partners |
Simeon Kohl
Chief Executive Officer & President
Ben Albert
Chief Business Officer
Jason Alger
Chief Financial Officer
Ryan Barry
Chief Client Services Officer
Lynne Dossey
Chief Growth Officer
Robbie Hughes
Chief Product Officer
Chris Tyne
Chief Engineering Officer
Carrie Kozlowski
Chief Marketing Officer
Becky Vea
Chief Human Resources Officer
Ben Landry
General Counsel
Kevin Scharnhorst
Chief Information Security Officer
Kyle Salyers
Chief Strategy Officer & Senior Vice President of Corporate Development
Holly Rimmasch
Senior Vice President & Chief Clinical Officer
Jeff Selander
Senior Vice President, International
Allie Coronis
Senior Vice President, Tech-Enabled Managed Services, Chart Abstraction
Scott Mattila
General Manager, Intraprise & Cybersecurity
Lisa Rhind
General Manager, Interoperability
Justin Spencer
Chair of the Board
Competitor list is illustrative and may be incomplete, stale, or erroneous.
Innovaccer
Healthcare data activation platform with unified patient records, population health and AI analytics; top-ranked in KLAS 2025 data & analytics.
Arcadia
Healthcare data platform focused on value-based care performance, population health analytics and risk adjustment.
Epic Systems
Dominant EHR vendor whose Cogito and Caboodle analytics offerings compete with third-party data platforms inside large health systems.
Optum (UnitedHealth Group)
Payer-owned analytics and services arm offering healthcare data, analytics and population health management to providers and plans.
Premier, Inc.
Group purchasing organization and healthcare improvement company with performance analytics and supply chain data products.
Strata Decision Technology
Cloud financial planning and analytics platform for hospitals and health systems.
Yes, Health Catalyst is publicly traded under the ticker symbol HCAT on the NASDAQ. The company went public in Jul 25, 2019.
Health Catalyst trades under the ticker symbol HCAT on the NASDAQ. It began trading in Jul 25, 2019.
Health Catalyst (HCAT on the NASDAQ) shares can be purchased through any standard brokerage account — including Fidelity, Charles Schwab, TD Ameritrade, and online platforms like Robinhood or E*TRADE. Search for the ticker HCAT to place an order.
Health Catalyst went public in Jul 25, 2019 via ipo, with an offering valuation of approximately $1B. Health Catalyst completed its initial public offering on Nasdaq Global Select Market under the ticker HCAT, with shares beginning trading on July 25, 2019, at an IPO price of $26.00 per share. The 7.0 million share offering raised approximately $182M in gross proceeds. The company has been publicly traded since.
Health Catalyst raised $377M across 8 disclosed funding rounds prior to its public listing.
Health Catalyst is headquartered in South Jordan, Utah, USA.
Access live market data
Sign UpData collected with AI, which can make mistakes. Please double-check this information.